Home
- Eating Well (or at Least Not terribly) at Fast Food Resturants
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Products Articles
Popular Products Articles
Highly Recommended Products Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
FDA Approves Indian Drug Maker’s Diabetes Drug Trial
Cadilia Pharmaceuticals
The drug discussed below is for the treatment of type 2 diabetes.
The Food and Drug Administration has given Cadila Healthcare the go-ahead to conduct U.S. trials of its ZYGK1 drug for treating diabetes.
Cadila is a pharmaceutical company based in Ahmedabad, in India's Gujarat state. The firm does business in 90 countries.
ZYGK1 is an orally administered drug that acts as a glucose sensor in the pancreas and regulates glucose metabolism in the liver. It is considered a "new molecular entity," a chemical that has not been seen before in drugs. Because of its newness, an NME undergoes particularly intense scrutiny to prove its effectiveness and safety.
At this time, neither Cadila nor the FDA has given specifics about how the U.S. tests will proceed.
Categories: Athletes, Diabetes, Diabetes, Food, Health, Health Care, Products, Research, Type 2 Issues
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
I assume this is for type 2? Any type 1 benefit?
Very curious to know if we are talking about Type I or not. That would be wonderful.
Whether we are talking about Type 1 or Type 2, it is curious that other countries are making strides in new areas that the US has not ventured into.
I am so tired of all diabetics being lumped together!!!! Please, let's give Type 1 a different name, since it is completely different, but most anyone who doesn't have it doesn't realize this. I certainly would have thought that an article published by Diabetes Health would have at least made the distinction.
For a Diabetic publication not to clarify in your blurp if your talking type 1 or type 2 surprises me. nevertheless a sensor in a pancreas that is "non insulin producing" would be senseless and a signal that it is for type 2 Correct??????
If this Trial affects Type 1 I volunteer in advance!
i m a diabetologist in mumbai,India,Dr R.K.,any advance is most welcome
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...